Oxford Biomedica PLC TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES. (1165A)
December 18 2014 - 2:00AM
UK Regulatory
TIDMOXB
RNS Number : 1165A
Oxford Biomedica PLC
18 December 2014
For filings with the FCA include the
annex
For filings with issuer exclude the
annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
1. Identity of the issuer or the underlying Oxford BioMedica plc
issuer
of existing shares to which voting rights
are
attached: (ii)
----------------------------------
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights X
-------------------------------------------------------------------------------- -------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
-------------------------------------------------------------------------------- -------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
-------------------------------------------------------------------------------- -------
An event changing the breakdown of voting rights
-------------------------------------------------------------------------------- -------
Other (please
specify):
------------------- ----------------------------------------------------------- -------
3. Full name of person(s) subject Third National Swedish Pension Fund,
to the AP3, Sweden
notification obligation: (iii)
-------------------------------------------
4. Full name of shareholder(s)
(if different from 3.):(iv)
-------------------------------------------
5. Date of the transaction and date 12 December 2014
on
which the threshold is crossed
or
reached: (v)
-------------------------------------------
6. Date on which issuer notified: 17 December 2014
-------------------------------------------
7. Threshold(s) that is/are crossed
or
reached: (vi, vii) 3%
-------------------------------------------
8. Notified details:
A: Voting rights attached to shares (viii, ix)
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN
CODE
--------------------------------- -------------------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights (x)
Shares Voting
Rights
------------- ------------------ ------------- ------------------------- -------------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
--- ------ ------ ----- --- ------------- -------------- --------- ---------------- -------------
GB006648157 85,797,333 85,797,333 3.3443
------------- ------------------ ------------- -------------- --------- ---------------- -------------
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period rights that may rights
(xiv) be
acquired if the
instrument is
exercised/ converted.
-------------- ------------------------------- ------------------------------ --------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments (xv, xvi)
Resulting situation after the triggering transaction
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date (xvii) Conversion rights instrument (xix, xx)
instrument period refers to
(xviii)
----------- ------------- ------------------ ------------------------------- -------------------------
Nominal Delta
----------- ------------- ------------------ ------------------------------- ------------- ----------
Total (A+B+C)
Number of voting rights Percentage of voting rights
------------------------------------------------------------
85,797,333 3.3443
------------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
Proxy Voting:
10. Name of the proxy holder:
---------------------------
11. Number of voting rights proxy holder will
cease
to hold:
---------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
---------------------------
13. Additional information:
14. Contact name: Tim Watts, Chief Financial Officer,
Oxford BioMedica
--------------------------------------
15. Contact telephone number: +44 (0) 1865 783 000
--------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLFMMMZZNMGDZZ
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Oxford Biomedica (LSE:OXB)
Historical Stock Chart
From Apr 2023 to Apr 2024
